Bond AbbVie 1.5% ( XS2117754593 ) in EUR
| Issuer | AbbVie | ||||||||||||||||||
| Market price | 100.00 % ⇌ | ||||||||||||||||||
| Country | United States
|
||||||||||||||||||
| ISIN code |
XS2117754593 ( in EUR )
|
||||||||||||||||||
| Interest rate | 1.5% per year ( payment 1 time a year) | ||||||||||||||||||
| Maturity | 14/11/2023 - Bond has expired | ||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||
| Minimal amount | 100 000 EUR | ||||||||||||||||||
| Total amount | 433 228 000 EUR | ||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in EUR, with the ISIN code XS2117754593, pays a coupon of 1.5% per year. The coupons are paid 1 time per year and the Bond maturity is 14/11/2023 |
||||||||||||||||||
| |||||||||||||||||||
Français
Italiano
United States